Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Obstructive sleep apnea (OSA) is a prevalent sleep disorder characterized by upper airway obstruction during sleep, leading to significant health issues and reduced quality of life. Despite its increasing prevalence, particularly among middle-aged and older adults, low awareness and treatment rates contribute to a substantial burden of disease uncertainty for both patients and their co-residents. This study aims to investigate the social and environmental determinants of disease uncertainty experienced by OSA patients and their co-residents, focusing on the impact of these factors on health behaviors and access to care.
Methods: The study employed the theoretical model of disease uncertainty as a guiding framework and utilized the KJ method for data analysis. Using purposive sampling, 13 OSA patients and their 13 co-residents were selected to form dyads. Ethical approval was obtained, and informed consent was secured from all participants prior to the study.
Results: The analysis of the interview data yielded seven major themes and 19 sub-themes. (1) "The Shadow of Knowing Little"; (2) "The Fog of Night and Day"; (3) "Symbiotic Suffering"; (4) "The Hidden Costs"; (5) "Delay in Seeking Medical Care"; (6) "Complex Choices"; (7) "Vacancies Calling for Attention."
Conclusion: The findings underscore that OSA patients and their co-residents face considerable uncertainty related to disease awareness, symptom experiences, medical decision-making, treatment plans, and social support. This uncertainty leads to delays in seeking care and poor treatment adherence. To mitigate these issues, it is recommended to enhance public health education on OSA, improve disease awareness and self-management skills among patients and their families, and better integrate medical resources and social support networks. These interventions should address the social and environmental determinants of health to reduce the burden of disease uncertainty and improve overall health outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378041 | PMC |
| http://dx.doi.org/10.3389/fneur.2025.1582173 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cost-Effectiveness of Treatment for Opioid Use Disorder in Pregnancy and Its Impact on Birth Outcomes.
JAMA Pediatr
September 2025
Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Importance: For the first time in nearly 2 decades, the US infant mortality rate has increased, coinciding with a rise in overdose-related deaths as a leading cause of pregnancy-associated mortality in some states. Prematurity and low birth weight-often linked to opioid use in pregnancy-are major contributors.
Objective: To assess the health and economic impact of perinatal opioid use disorder (OUD) treatment on maternal and postpartum health, infant health in the first year of life, and infant long-term health.
Inhibitory activities of monoclonal antibodies against clumping factor A.
mBio
September 2025
Department of Microbiology, Howard Taylor Ricketts Laboratory, The University of Chicago, Lemont, Illinois, USA.
infection is a frequent cause of sepsis in humans, a disease associated with high mortality and without specific intervention. Clumping factor A (ClfA) displayed on the bacterial surface plays a key role in promoting replication during invasive disease. Decades of research have pointed to a wide array of ligands engaged by ClfA.
View Article and Find Full Text PDFAttitudes of a Hemato-Oncology Team Toward Referring Patients to Palliative Care: A Qualitative Study.
Palliat Med Rep
August 2025
Palliative Medicine Program, Clínica Universitaria Colombia, Bogotá, Colombia.
Objective: International literature suggests that patients with hematological diseases are frequently referred to palliative care (PC) at a late stage. This study aims to explore the attitudes of a hemato-oncology care team toward referring patients to the PC in a fourth-level hospital in Bogotá, Distrito Capital.
Methods: This exploratory qualitative study was conducted through in-person focus groups between May 2024 and October 2024 at Clínica Universitaria Colombia in Bogotá, Colombia.
Burden and trends of ovarian and uterine cancer due to high body mass index from 1990 to 2021: an age-period-cohort study based on the GBD 2021, and projections through 2036.
Front Oncol
August 2025
Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Background: Ovarian cancer (OC) and uterine cancer (UC) are significant public health concerns among women of reproductive age. High body mass index (BMI) contributes to the increasing burden of these cancers globally, but comprehensive epidemiological assessments remain limited.
Methods: Data were obtained from the Global Burden of Disease (GBD) Study 2021 (1990-2021).
Unraveling Etiological Indications and Therapeutic Implications of Familial Cerebral Cavernous Malformations in the Dawn of Gene Therapy for Monogenic Conditions.
Curr Gene Ther
August 2025
State Key Laboratory of Vascular Homeostasis and Remodeling, Department of Neurosurgery, Peking University Third Hospital, Peking University, Beijing 100191, China.
Cerebral Cavernous Malformations (CCMs) are vascular anomalies in the central nervous system that arise from both genetic and non-genetic factors, and can cause hemorrhage, seizures, and neurological deficits. Approximately 80% of CCMs are sporadic, while 20% are Familial (FCCMs), an autosomal dominant, monogenic disorder characterized by multiple lesions and severe clinical manifestations. Over the past three decades, linkage analyses have identified KRIT1/CCM1, MGC4607/CCM2, and PDCD10/CCM3 as major pathogenic genes in FCCMs.
View Article and Find Full Text PDF